• KidneyIntelX™ demonstrates ability to assess risk of heart failure hospitalization and death in large international diabetic kidney disease patient cohort. Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease.
  • Late-breaking data presented at American Diabetes Association Scientific Sessions® demonstrates increased adherence to care guidelines for physicians using KidneyIntelX risk assessment to improve outcomes, alleviate patient suffering, and reduce significant financial burden associated with progressing chronic kidney disease.